The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
GlycoMimetics, Inc(NASDAQ:GLYC) 
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. The company's drug candidate include rivipansel, a pan-selectin antagonist for the treatment ...
Website: http://www.glycomimetics.com
Founded: 2003
Full Time Employees: 57
Founder: Rachel K. King
Sector: Healthcare
Industry: Biotechnology
GlycoMimetics Days Payable Outstanding ttm (DPO)
GlycoMimetics Days Receivable Outstanding ttm (DSO)
GlycoMimetics Days Inventory Outstanding ttm (DIO)
GlycoMimetics Op Cashflow Per Share ttm
GlycoMimetics Free Cashflow Per Share ttm
GlycoMimetics Cash Per Share ttm
GlycoMimetics P/S ratio ttm
GlycoMimetics (GAAP) P/E ratio ttm
GlycoMimetics P/B ratio ttm
No extra charts and metrics for this ticker.